Altana

News

INTERVIEW – Option Finance

30/09/2014 - Articles and publications

Jean-Nicolas Soret and the CFO of Onxeo were interviewed in relation to the cross-border merger of French listed company BioAlliance Pharma and Danish listed company Topotarget, resulting in the formation of Onxeo.

Click here to read the interview